Renal Cancer - Results from #5640

Survival Analyses of Metastatic Renal Cancer Patients Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study June 26, 2016

Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome June 24, 2016

Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials June 24, 2016

[Immune Checkpoint for a Kidney Cancer and Other Cancers] June 23, 2016

[Social medicine assessment after surgical and targeted treatment of renal cell cancer] June 23, 2016

Renal Carcinogenesis, Tumor Heterogeneity, and ROS: The Devil wears Prada June 23, 2016

Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity June 23, 2016

The Application of Digital Pathology to Improve Accuracy in Glomerular Enumeration in Renal Biopsies June 22, 2016

Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab June 22, 2016

The development of immunotherapy in older adults: New treatments, new toxicities? June 20, 2016

Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium June 20, 2016

Pediatric Clear Cell Renal Cell Carcinoma with Pelvicalyceal System Invasion and Contiguous Extension Upto Bladder: Novel and Bizarre Tumor Behaviour June 17, 2016

TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma. June 17, 2016

Renal Cancer Stem Cells: Characterization and Targeted Therapies June 17, 2016

Immune Checkpoint Inhibitors in Older Adults June 17, 2016

Morbidity and Mortality of Radical Nephrectomy for Patients with Disseminated Cancer - an Analysis of the National Surgical Quality Improvement Program Database June 16, 2016

Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma. June 16, 2016

Percutaneous radiofrequency ablation of renal tumors in high-risk patients: 10 years' experience June 13, 2016

Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data June 10, 2016

Pharmacokinetics and excretion of (14)C-omacetaxine in patients with advanced solid tumors June 10, 2016

Page 283 of 456